Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole oral suspension for esophageal candidiasis
NCT00002339Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fluconazole in esophageal candidiasis, sponsored by Pfizer. Primary endpoints: Safety and Toleration and Efficacy. Status: completed.
02
Drugs
fluconazole
03
Conditions
esophageal candidiasis
Beyond the preview
Go deeper on NCT00002339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002339.